更新关于 levetiracetam 相关的严重皮肤不良反应的见解:现实世界的药监测分析
Zhanshen Wu1, Yang Zhao1, Xiangyu Zhang1
1Department of Pharmacy, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
列维 (LEV) 与严重的皮肤不良反应 (SCAR) 有关,大多数风险发生在治疗的第一周内. 监测LEV的使用对于患者的安全至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 皮肤病学 皮肤病学
- 神经学 神经学
背景情况:
- 之前关于 levetiracetam (LEV) 和严重皮肤不良反应 (SCARs) 的研究依赖于有限的数据,不清楚现实世界的关联.
- 了解不同患者群体中LEV和SCAR之间的精确关系对于安全的处方实践至关重要.
研究的目的:
- 使用大规模的真实世界数据调查 levetiracetam (LEV) 和严重皮肤不良反应 (SCARs) 之间的关联.
- 为了确定与LEV诱导的SCAR相关的风险因素和时间模式.
主要方法:
- 分析来自FDA不良事件报告系统 (FAERS) 和EudraVigilance数据库的数据.
- 使用不成比例分析和单变量逻辑回归来评估LEV-SCAR关联并确定风险因素.
主要成果:
- 在 levetiracetam (LEV) 和严重皮肤不良反应 (SCARs) 之间发现了显著的相关性 (p < 0.05).
- 与其他抗药物相比,LEV与SCAR的相关性较弱 (p < 0.05).
- 与LEV相关的SCARs的危险因素包括男性性别,年龄45-65岁,以及同时使用eslicarbazepine,phenytoin,carbamazepine或lamotrigine. 超过39%的SCAR发生在LEV治疗的第一周内.
结论:
- 这项研究提供了关于 levetiracetam (LEV) 与严重皮肤不良反应 (SCARs) 之间的现实世界关联的最新见解.
- 这些发现强调了警监测和积极管理LEV相关的SCARs的重要性,以确保患者的安全并优化治疗结果.
更多相关视频
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drug Absorption: Overview
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
Pharmacokinetics: Overview
Analysis of Population Pharmacokinetic Data
